Fairvalue-Calculator Fairvalue-Calculator
EN DE

Monash IVF Group (MNIVF) Fair Value & Analysis

Healthcare · US · Market cap $156M

Price$0.4000
Fair Value$0.5900
Upside+47.5%
Quality82/100
Evidence: Medium Range $0.3700 – $0.8000

Fair value as of: Jun 25, 2026

Analysis

Monash IVF Group (MNIVF) currently trades at $0.4000, while our model-based Fair Value estimate is $0.5900 — implying the stock looks roughly 47.5% undervalued today. We read business quality at 82/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

Monash IVF Group Limited engages in the provision of assisted reproductive and specialist women imaging services in Australia and Malaysia. It offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. It also provides tertiary level prenatal diagnostic, and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is headquartered in Richmond, Australia.

Open the full interactive analysis →

Similar stocks

Thermo Fisher Scientific Inc (TMO) -96% Danaher Corporation (DHR) -52% WuXi AppTec Co (WUXAY) +35% IDEXX Laboratories, Inc (IDXX) -66% Lonza Group (LZAGY) -59% Agilent Technologies, Inc (A) -54%

Frequently asked questions

Is Monash IVF Group (MNIVF) undervalued?
As of Jun 25, 2026, our model estimates a fair value of $0.5900 versus a price of $0.4000 — about +48% (undervalued). Model-based estimate, not financial advice.
What is the fair value of MNIVF?
Our 21-model fair value for Monash IVF Group is $0.5900 (as of Jun 25, 2026), built from audited fundamentals. The current price is $0.4000.
What is the quality score of MNIVF?
Monash IVF Group has a Quality Score of 82/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.